Literature DB >> 29618412

Loss of endothelial nitric oxide synthase exacerbates intestinal and lung injury in experimental necrotizing enterocolitis.

Natalie A Drucker1, Amanda R Jensen1, Jan P Te Winkel1, Michael J Ferkowicz1, Troy A Markel2.   

Abstract

BACKGROUND: Necrotizing enterocolitis (NEC) continues to be a devastating condition among preterm infants. Nitric oxide, which is synthesized in the intestine by endothelial nitric oxide synthase (eNOS), acts as a potent vasodilator and antioxidant within the mesentery and may play a role in prevention of NEC. We hypothesized that loss of endothelial nitric oxide would worsen both intestinal and associated lung injury and increase local and systemic inflammation during experimental NEC.
METHODS: NEC was induced in five-day-old wild type (WT) and eNOS-knockout (eNOSKO) mouse pups. Experimental groups (n=10) were formula fed and subjected to intermittent hypoxic and hypothermic stress, while control groups (n=10) remained with their mother to breastfeed. Pups were monitored by daily clinical assessment. After sacrifice on day nine, intestine and lung were assessed for injury, and cytokines were measured in tissue homogenates by ELISA. Data were compared with Mann-Whitney, and p<0.05 was significant.
RESULTS: Each NEC group was compared to its respective strain's breastfed control to facilitate comparisons between the groups. Both NEC groups were significantly sicker than their breastfed controls. eNOSKO NEC animals had a median clinical assessment score of 3 (IQR=1-5), and the WT NEC animal's median score was 3 (IQR=2-5). Despite similar clinical scores, intestinal injury was significantly worse in the eNOSKO NEC groups compared to WT NEC groups (median injury scores of 3.25 (IQR=2.25-3.625) and 2 (IQR=1-3), respectively (p=0.0474). Associated lung injury was significantly worse in the eNOSKO NEC group as compared to the WT NEC group (median scores of 8.5 (IQR=6.75-11.25) and 6.5 (IQR=5-7.5), respectively, p=0.0391). Interestingly, cytokines in both tissues were very different between the two groups, with varying effects noted for each cytokine (IL-6, IL-1β, VEGF, and IL-12) in both tissues.
CONCLUSION: Nitric oxide from eNOS plays a key role in preventing the development of NEC. Without eNOS function, both intestinal and lung injuries are more severe, and the inflammatory cascade is significantly altered. Further studies are needed to determine how eNOS-derived nitric oxide facilitates these beneficial effects.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Animal model; Intestine; Ischemia; Necrotizing enterocolitis; Neonatal; Nitric oxide

Mesh:

Substances:

Year:  2018        PMID: 29618412      PMCID: PMC5994357          DOI: 10.1016/j.jpedsurg.2018.02.087

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  32 in total

1.  Macrophage endothelial nitric-oxide synthase autoregulates cellular activation and pro-inflammatory protein expression.

Authors:  Linda Connelly; Aaron T Jacobs; Miriam Palacios-Callender; Salvador Moncada; Adrian J Hobbs
Journal:  J Biol Chem       Date:  2003-05-09       Impact factor: 5.157

2.  Nitric oxide modulates regional blood flow differences in the fetal gastrointestinal tract.

Authors:  W Q Fan; J J Smolich; J Wild; V Y Yu; A M Walker
Journal:  Am J Physiol       Date:  1996-10

3.  An official American Thoracic Society workshop report: features and measurements of experimental acute lung injury in animals.

Authors:  Gustavo Matute-Bello; Gregory Downey; Bethany B Moore; Steve D Groshong; Michael A Matthay; Arthur S Slutsky; Wolfgang M Kuebler
Journal:  Am J Respir Cell Mol Biol       Date:  2011-05       Impact factor: 6.914

Review 4.  Cytokines in necrotizing enterocolitis.

Authors:  Troy A Markel; Paul R Crisostomo; George M Wairiuko; Jeffrey Pitcher; Ben M Tsai; Daniel R Meldrum
Journal:  Shock       Date:  2006-04       Impact factor: 3.454

Review 5.  Necrotizing enterocolitis.

Authors:  Josef Neu; W Allan Walker
Journal:  N Engl J Med       Date:  2011-01-20       Impact factor: 91.245

6.  Lack of VEGFR2 signaling causes maldevelopment of the intestinal microvasculature and facilitates necrotizing enterocolitis in neonatal mice.

Authors:  Xiaocai Yan; Elizabeth Managlia; Shirley Xl Liu; Xiao-Di Tan; Xiao Wang; Catherine Marek; Isabelle G De Plaen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-02-25       Impact factor: 4.052

Review 7.  The role of the intestinal microcirculation in necrotizing enterocolitis.

Authors:  Daniel J Watkins; Gail E Besner
Journal:  Semin Pediatr Surg       Date:  2013-05       Impact factor: 2.754

8.  Chronic lung disease and developmental delay at 2 years of age in children born before 28 weeks' gestation.

Authors:  Matthew Laughon; Michael T O'Shea; Elizabeth N Allred; Carl Bose; Karl Kuban; Linda J Van Marter; Richard A Ehrenkranz; Alan Leviton
Journal:  Pediatrics       Date:  2009-07-20       Impact factor: 7.124

9.  Enteral feeding reduces endothelial nitric oxide synthase in the caudal intestinal microvasculature of preterm piglets.

Authors:  Els R van Haver; Marijke Oste; Thomas Thymann; Stanislas U Sys; Wouter H Lamers; Andre L M Weyns; Per T Sangild; Christa J van Ginneken
Journal:  Pediatr Res       Date:  2008-02       Impact factor: 3.756

10.  Pediatric short-bowel syndrome: the cost of comprehensive care.

Authors:  Ariel U Spencer; Debra Kovacevich; Michelle McKinney-Barnett; Deanna Hair; Julie Canham; Christopher Maksym; Daniel H Teitelbaum
Journal:  Am J Clin Nutr       Date:  2008-12       Impact factor: 7.045

View more
  8 in total

1.  Hydrogen Sulfide Donor GYY4137 Acts Through Endothelial Nitric Oxide to Protect Intestine in Murine Models of Necrotizing Enterocolitis and Intestinal Ischemia.

Authors:  Natalie A Drucker; Amanda R Jensen; Jan P Te Winkel; Troy A Markel
Journal:  J Surg Res       Date:  2018-10-23       Impact factor: 2.192

2.  Inhibiting hydrogen sulfide production in umbilical stem cells reduces their protective effects during experimental necrotizing enterocolitis.

Authors:  Natalie A Drucker; Jan P Te Winkel; W Christopher Shelley; Kenneth R Olson; Troy A Markel
Journal:  J Pediatr Surg       Date:  2019-03-01       Impact factor: 2.545

Review 3.  Oxygen radical disease in the newborn, revisited: Oxidative stress and disease in the newborn period.

Authors:  Marta Perez; Mary E Robbins; Cecilie Revhaug; Ola D Saugstad
Journal:  Free Radic Biol Med       Date:  2019-04-05       Impact factor: 7.376

4.  The administration of a pre-digested fat-enriched formula prevents necrotising enterocolitis-induced lung injury in mice.

Authors:  Chhinder P Sodhi; Andres J Gonzalez Salazar; Mark L Kovler; William B Fulton; Yukihiro Yamaguchi; Asuka Ishiyama; Sanxia Wang; Thomas Prindle; Mustafa Vurma; Tapas Das; Hongpeng Jia; Peng Lu; David J Hackam
Journal:  Br J Nutr       Date:  2021-10-11       Impact factor: 3.718

5.  A hydrogen-sulfide derivative of mesalamine reduces the severity of intestinal and lung injury in necrotizing enterocolitis through endothelial nitric oxide synthase.

Authors:  Brian D Hosfield; Chelsea E Hunter; Hongge Li; Natalie A Drucker; Anthony R Pecoraro; Krishna Manohar; W Christopher Shelley; Troy A Markel
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2022-08-01       Impact factor: 3.210

Review 6.  Bench to bedside - new insights into the pathogenesis of necrotizing enterocolitis.

Authors:  David J Hackam; Chhinder P Sodhi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-03-28       Impact factor: 73.082

Review 7.  Postnatal Sepsis and Bronchopulmonary Dysplasia in Premature Infants: Mechanistic Insights into "New BPD".

Authors:  Umar Salimi; Krishna Dummula; Megan H Tucker; Charles S Dela Cruz; Venkatesh Sampath
Journal:  Am J Respir Cell Mol Biol       Date:  2022-02       Impact factor: 7.748

Review 8.  Endothelial Damage in Acute Respiratory Distress Syndrome.

Authors:  Alice G Vassiliou; Anastasia Kotanidou; Ioanna Dimopoulou; Stylianos E Orfanos
Journal:  Int J Mol Sci       Date:  2020-11-20       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.